HSCS
HeartSciences Inc.NASDAQHealthcare$2.30-2.54%ClosedMarket Cap: $5.0M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.69
P/S
565.00
EV/EBITDA
442.54
DCF Value
$-1.71
FCF Yield
-117503.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
-1060.2%
Operating Margin
-89939.6%
Net Margin
-97881.0%
ROE
-333.4%
ROA
-112.3%
ROIC
-119.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2026 | $0.00 | -Infinity% | $-1.9M | $-2.0M | $-0.63 | — |
| Q2 2026 | $2.4K | -1282.5% | $-2.1M | $-2.4M | $-0.85 | — |
| Q1 2026 | $1.9K | 60.0% | $-1.9M | $-2.1M | $-1.58 | — |
| Q4 2025 | $4.3K | -661.9% | $-1.9M | $-2.1M | $-1.88 | — |
| FY 2025 | $4.3K | -2884.7% | $-8.4M | $-8.8M | $-9.34 | — |
| Q3 2025 | $0.00 | NaN% | $-2.4M | $-2.5M | $-2.57 | — |
| Q2 2025 | $0.00 | -Infinity% | $-2.0M | $-2.1M | $-2.27 | — |
| Q1 2025 | $0.00 | -Infinity% | $-2.1M | $-2.1M | $-2.64 | — |
| Q4 2024 | $0.00 | -Infinity% | $-1.9M | $-1.8M | $-2.73 | — |
| FY 2024 | $18.6K | -444.2% | $-6.3M | $-6.6M | $-18.74 | — |
| Q3 2024 | $14.7K | 43.7% | $-1.5M | $-1.6M | $-3.06 | — |
| Q2 2024 | $3.9K | -134.8% | $-1.6M | $-1.7M | $-15.98 | — |